All the news Showing 10 of 10 articles from: AustriaGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis delta Bulevirtide for hepatitis D proves effective in real-world studies Liz Highleyman / 25 January 2022 The entry inhibitor bulevirtide (Hepcludex) led to a reduction in hepatitis delta virus (HDV) viral load and improved liver enzyme levels in real-world studies in France and Austria, according to findings presented ... Treatment for people who use drugs Directly observed treatment for hepatitis C highly effective in people who inject drugs Keith Alcorn / 14 April 2020 Directly observed treatment for hepatitis C achieved a very high cure rate in people who inject drugs, an Austrian study carried out in pharmacies and drugs projects offering opioid substitution therapy has reported. The ... Sexual transmission Hepatitis C is detectable in rectal and nasal fluid Keith Alcorn / 12 November 2018 High levels of hepatitis C virus (HCV) can be found in the rectal and nasal fluids of people with high hepatitis C viral loads even when blood is not present, Austrian researchers ... Treatment outcomes Does portal hypertension always improve after hepatitis C cure? Keith Alcorn / 10 May 2018 Although portal hypertension improves in the majority of people with hepatitis C and cirrhosis after hepatitis C is cured, not all people experience improvement, and oesophageal varices may continue to ... Sexual transmission Hepatitis C infection and reinfection among men who have sex with men Liz Highleyman / 29 September 2016 Public health officials in Michigan have identified a cluster of more than 20 cases of apparently sexually transmitted hepatitis C virus (HCV) infection among HIV-positive gay and bisexual men, according to a report ... Sexual transmission High incidence of HCV reinfection among HIV-positive MSM in Western Europe Michael Carter / 19 April 2016 There is a very high incidence of hepatitis C virus (HCV) reinfection among HIV-positive men who have sex with men (MSM) in western Europe, according to research presented to the International Liver Congress ... Promoting hepatitis testing General practitioners urged to test for viral hepatitis in all patients with liver abnormalities Caspar Thomson / 29 July 2013 General practitioners in Europe need to be more alert for possible signs of viral hepatitis and test patients accordingly, the spokesperson for Europe’s liver disease specialists said on Friday. Speaking at a press ... Triple therapy Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis Keith Alcorn / 30 April 2013 Currently available triple therapies for hepatitis C carry a high risk of serious side-effects for people in the most urgent need of treatment, and these patients have only a moderate chance of being ... Treatment issues Vitamin D deficiency associated with a poorer response to HCV treatment in HIV/HCV-co-infected patients Michael Carter / 11 October 2012 Vitamin D deficiency is associated with a poorer response to hepatitis C therapy in people who are co-infected with HIV and hepatitis C, investigators report in the online edition of AIDS. Austrian ... Treatment issues HIV treatment preserves CD4 cell count during and after HCV therapy in co-infected patients Michael Carter / 03 May 2011 Antiretroviral therapy helps preserve the CD4 cell counts of HIV-positive patients undergoing treatment for hepatitis C, Austrian investigators report in the June 15th edition of the Journal of Infectious Diseases. Treatment with ... ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive